Zum Inhalt springen

NOF PRESENTS at 8th International mRNA Health Conference

8th International mRNA Health Conference

–VIRTUAL–

11/06/2020 by NOF Europe GmbH

NOF CORPORATION will present NOF DDS technology for Nucleic Acid Therapeutics and Vaccines at 8th International mRNA Health Conference –VIRTUAL– to be held from November 9 to 10, 2020.

Conference Website: https://www.mrna-conference.com/


Presentation Title: COATSOME® SS-Lipids as novel, biodegradable, ionizable Lipids for mRNA Therapeutics and Vaccines

Date and time: Monday, November 9, 2020 12:40 – 12:55 pm (Eastern Standard Time)

Abstract:

COATSOME® SS-Lipid, a novel lipid platform for nucleic acid delivery is composed of highly biodegradable, ionizable lipids. Rational engineering of functional groups of the lipid to improve biodegradation in the cytoplasm was shown to vastly improve gene expression while at the same time reducing hepatic toxicity. Here we detail the chemistry and biology of LNP-mRNA complexes and preclinical data for a CRISPR-Cas9 genome editing therapeutic and a mRNA vaccine program.

This presentation will be available on demand until November 30, 2020.

Please contact our regional offices below for the detail of the presentation or if you have any questions for the contents of the presentation.

Americas
NOF AMERICA CORPORATION
E-mail: info@nofamerica.com
Tel: NY Office: +1-914-681-9790
CA Office: +1-650-993-7375

Europe
NOF EUROPE GmbH
E-mail: info@nofeurope.com
Tel: +49 (0)69 7706 100 0

Asia Pacific
NOF CORPORATION
DDS Development Division
E-mail: ddsinfo@nof.co.jp

China
NOF (Shanghai) Co. Ltd.
E-mail: info@nof.cn
Tel: +86-21-6210-1100